Search research articles
Contact Us
Filters
Showing results (211-220 of 324) with videos related to
Page
of 33
Sort By:
Cancer Communications (London, England)
|
May 10, 2019
The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer
Zhi-Qiang Wang, Fei Zhang, Ting Deng, et al.
Chemotherapy
|
June 19, 2008
A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer
Hui-Yan Luo, Rui-Hua Xu, Li Zhang, et al.
Neuropsychiatric Disease and Treatment
|
February 19, 2021
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
Chao Zhang, Jun Zhong, Wei-Xiang Chen, et al.
The International Journal of Biological Markers
|
January 19, 2010
Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma
Miao-zhen Qiu, Jun-zhong Lin, Zhi-qiang Wang, et al.
Therapeutic Advances in Medical Oncology
|
January 22, 2026
A clinical-molecular nomogram for predicting early recurrence following resection of initially unresectable colorectal liver metastases
Yu-Ting Lu, Xiao-Xia Huang, Wen-Chuan Chen, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
December 25, 2003
[Preliminary study of lyophilized 10-hydroxycamptothecin in advanced or recurrent malignancies]
Hui-Qiang Huang, Wen-Qi Jiang, Xiao-Hua Hu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
June 20, 2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma]
Xiao-fei Sun, Zi-jun Zhen, Dong-geng Liu, et al.
Therapeutic Advances in Medical Oncology
|
March 1, 2024
Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases
Zhi-Gang Chen, Xiao-Meng Ji, Yu-Xia Xu, et al.
Cancer
|
May 8, 2014
MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy
Xin An, Fang Wang, Qiong Shao, et al.
Oncotargets and Therapy
|
November 2, 2017
<i>FcγRIIA</i> and <i>IIIA</i> polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
De-Shen Wang, Xiao-Li Wei, Zhi-Qiang Wang, et al.
Page
of 33
Search research articles
Search
Showing results (211-220 of 324) with videos related to
Sort By:
Page
of 33
Cancer Communications (London, England)
|
May 10, 2019
The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer
Zhi-Qiang Wang, Fei Zhang, Ting Deng, et al.
Chemotherapy
|
June 19, 2008
A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer
Hui-Yan Luo, Rui-Hua Xu, Li Zhang, et al.
Neuropsychiatric Disease and Treatment
|
February 19, 2021
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
Chao Zhang, Jun Zhong, Wei-Xiang Chen, et al.
The International Journal of Biological Markers
|
January 19, 2010
Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma
Miao-zhen Qiu, Jun-zhong Lin, Zhi-qiang Wang, et al.
Therapeutic Advances in Medical Oncology
|
January 22, 2026
A clinical-molecular nomogram for predicting early recurrence following resection of initially unresectable colorectal liver metastases
Yu-Ting Lu, Xiao-Xia Huang, Wen-Chuan Chen, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
December 25, 2003
[Preliminary study of lyophilized 10-hydroxycamptothecin in advanced or recurrent malignancies]
Hui-Qiang Huang, Wen-Qi Jiang, Xiao-Hua Hu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
June 20, 2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma]
Xiao-fei Sun, Zi-jun Zhen, Dong-geng Liu, et al.
Therapeutic Advances in Medical Oncology
|
March 1, 2024
Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases
Zhi-Gang Chen, Xiao-Meng Ji, Yu-Xia Xu, et al.
Cancer
|
May 8, 2014
MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy
Xin An, Fang Wang, Qiong Shao, et al.
Oncotargets and Therapy
|
November 2, 2017
<i>FcγRIIA</i> and <i>IIIA</i> polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
De-Shen Wang, Xiao-Li Wei, Zhi-Qiang Wang, et al.
Page
of 33